1 |
Jeffcoate WJ, Lipsky BA, Berendt AR, et al. Unresolved issues in the management of ulcers of the foot in diabetes[J]. Diabet Med, 2008, 25(12):1380-1389.
|
2 |
Snyder RJ, Lantis J, Kirsner RS, et al. Macrophages: A review of their role in wound healing and their therapeutic use[J]. Wound Repair Regen, 2016, 24(4):613-629.
|
3 |
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. Jama, 2013, 310(9):948-959.
|
4 |
Niu Y, Xie T, Ge K, et al. Effects of extracellular matrix glycosylation on proliferation and apoptosis of human dermal fibroblasts via the receptor for advanced glycosylated end products[J]. Am J Dermatopathol, 2008, 30(4):344-351.
|
5 |
Alexiou P, Chatzopoulou M, Pegklidou K, et al. RAGE: a multi-ligand receptor unveiling novel insights in health and disease[J]. Curr Med Chem, 2010, 17(21):2232-2252.
|
6 |
Chia JS, McRae JL, Thomas HE, et al. The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice[J]. Diabetes, 2013, 62(6):2026-2035.
|
7 |
Wear-Maggitti K, Lee J, Conejero A, et al. Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation[J]. Ann Plast Surg, 2004, 52(5):519-521; discussion 22.
|
8 |
Pradhan L, Nabzdyk C, Andersen ND, et al. Inflammation and neuropeptides: the connection in diabetic wound healing[J]. Expert Rev Mol Med, 2009, 11:e2.
|
9 |
Wicks K, Torbica T, Mace KA. Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound[J]. Semin Immunol, 2014, 26(4):341-353.
|
10 |
Okizaki S, Ito Y, Hosono K, et al. Suppressed recruitment of alternatively activated macrophages reduces TGF-beta1 and impairs wound healing in streptozotocin-induced diabetic mice[J]. Biomed Pharmacother, 2015, 70:317-325.
|
11 |
Haegens A, Vernooy JH, Heeringa P, et al. Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents[J]. Eur Respir J, 2008, 31(2):252-260.
|
12 |
Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker[J]. J Invest Dermatol, 1982, 78(3):206-209.
|
13 |
Rieger AM, Hall BE, Barreda DR. Macrophage activation differentially modulates particle binding, phagocytosis and downstream antimicrobial mechanisms[J]. Dev Comp Immunol, 2010, 34(11):1144-1159.
|
14 |
Sindrilaru A, Scharffetter-Kochanek K. Disclosure of the Culprits: Macrophages-Versatile Regulators of Wound Healing[J]. Adv Wound Care (New Rochelle), 2013, 2(7):357-368.
|
15 |
Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils[J]. Nat Immunol, 2011, 12(11):1035-1044.
|
16 |
Mantovani A, Biswas SK, Galdiero MR, et al. Macrophage plasticity and polarization in tissue repair and remodelling[J]. J Pathol, 2013, 229(2):176-185.
|